about
N-acetylcysteine for non-paracetamol drug-induced liver injury: a systematic review protocolResearch Advances on Hepatotoxicity of Herbal Medicines in ChinaSchisandrin B inhibits cell growth and induces cellular apoptosis and autophagy in mouse hepatocytes and macrophages: implications for its hepatotoxicity.I-131 remnant ablation after thyroidectomy induced hepatotoxicity in a case of thyroid cancer.Systematic Review of Adverse Effects from Herbal Drugs Reported in Randomized Controlled Trials.Clinical Features of Drug-induced Liver Injury According to Etiology.N-acetylcysteine for non-paracetamol drug-induced liver injury: a systematic review.Advances in the management of acute liver failure.Female gender as a susceptibility factor for drug-induced liver injury.Efficacy and tolerability of benzodiazepines for the treatment of behavioral and psychological symptoms of dementia: a systematic review of randomized controlled trials.Development and regulatory application of microRNA biomarkers.Successful salvage treatment of acute graft-versus-host disease after liver transplantation by withdrawal of immunosuppression: a case reportLiver injury after aluminum potassium sulfate and tannic acid treatment of hemorrhoids.Hepatitis B virus inhibits liver regeneration via epigenetic regulation of urokinase-type plasminogen activator.Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment?MITOsym®: A Mechanistic, Mathematical Model of Hepatocellular Respiration and Bioenergetics.Clinical and histological features of idiosyncratic liver injury: Dilemma in diagnosis of autoimmune hepatitis.Association study of UGT1A9 promoter polymorphisms with DILI based on systematically regional variation screen in Chinese population.Artificial liver support in pigs with acetaminophen-induced acute liver failure.A case of levocetirizine-induced liver injury.A Multicenter and Randomized Controlled Trial of Bicyclol in the Treatment of Statin-Induced Liver Injury.Autophagy in drug-induced liver toxicity.A modified multiparametric assay using HepaRG cells for predicting the degree of drug-induced liver injury risk.Agomelatine-induced liver injury in a patient with choledocholithiasis.Endogenous Antioxidant and LOX-Mediated Systems Contribute to the Hepatoprotective Activity of Aqueous Partition of Methanol Extract of Muntingia calabura L. Leaves against Paracetamol Intoxication.Blood Pyrrole-Protein Adducts--A Biomarker of Pyrrolizidine Alkaloid-Induced Liver Injury in Humans.In Vitro Drug-Induced Liver Injury Prediction: Criteria Optimization of Efflux Transporter IC50 and Physicochemical Properties.Herb-Induced Liver Injuries in Developing Nations: An UpdateProfile of Acute Liver Failure from North-east India and Its Differences from other Parts of the CountryApplication of Dendrimers for the Treatment of Infectious Diseases
P2860
Q27014948-6D1893F2-6F2F-4B5F-98FD-2FFFCB26BF99Q30239062-9CB7ED26-2E0F-4179-8AA6-EDA7C41D8621Q35490308-3559FCEE-7309-427C-B354-A79DA28931B5Q35623586-AFFCF345-3831-494C-9707-CE05A83D316FQ36022805-33FE390E-30F2-4BED-881A-176B3A73F449Q36400550-385392AC-1B9E-436C-8713-D3ECE34AE3C3Q36924709-50C51934-D8A9-4926-BB2E-872CC304692DQ37285277-C4845FF2-EB14-44B1-8032-5B1D2007D702Q38168331-F48FDBBD-6CA2-478C-A793-2E17792C91E8Q38304559-A14401AF-2362-412C-BEB5-9EA11BDCD0ECQ38616581-50646C0E-1A12-4845-9CFA-92838D0F238BQ38629951-350FF3AA-7901-43C0-BC50-263B5274397AQ38645739-C628C28D-6E25-4EBE-997E-F7E15A40D99AQ39181943-A56C839F-EEB2-4BDF-8F4E-9707E407D4C5Q39234138-5ECB2B0E-DE4B-4728-9A51-7510FC07A3FBQ40376380-DDD333BF-7E55-4614-80C1-7E91E504F898Q40995506-1BC77AD8-9CA8-4F0B-90C5-667EDE7E76D3Q41636182-56B4020A-531B-4047-A916-A708A1F6E4E7Q42261846-FEAD56E6-30DF-4219-8850-E12B759E77A8Q42327996-ED2A28EC-790C-4C1D-8C15-D9EE6B1CEB4FQ47096819-7F718856-21BE-4CFD-8A45-2CB911C61294Q47141835-26126DEC-E11D-41EE-9D23-7837CC7C8F5EQ48133015-E72B977D-4F34-4A73-9FFB-42A932284F70Q48187972-F3356502-A3A5-48CC-A2E8-09007CCAECF3Q50347917-6418CCEA-5248-4477-9233-AB3CED6891B2Q50559583-4246B7FB-4BFA-42D7-920F-A6144F6CAF06Q51075204-96DFFCA0-3677-4296-BCDC-E75E1080D93AQ56912365-FC550796-FB40-41AC-9F3E-B8EC0D1795D4Q56996809-D76D9350-6909-418D-B5A7-FDB5FC7888A9Q58696083-0DA96B65-58FD-4FDD-B742-7A5D83D603A6
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Drug-induced liver injury: present and future
@ast
Drug-induced liver injury: present and future
@en
Drug-induced liver injury: present and future
@nl
type
label
Drug-induced liver injury: present and future
@ast
Drug-induced liver injury: present and future
@en
Drug-induced liver injury: present and future
@nl
prefLabel
Drug-induced liver injury: present and future
@ast
Drug-induced liver injury: present and future
@en
Drug-induced liver injury: present and future
@nl
P2860
P1476
Drug-induced liver injury: present and future
@en
P2093
Dong Joon Kim
Ki Tae Suk
P2860
P304
P356
10.3350/CMH.2012.18.3.249
P407
P577
2012-09-01T00:00:00Z